Cargando…

3318 Phosphorus Absorption in Healthy Adults and in Patients with Moderate Chronic Kidney Disease

OBJECTIVES/SPECIFIC AIMS: The aim of this study is to compare intestinal phosphorus absorption in healthy adults and moderate stage chronic kidney disease patients in the context of a controlled feeding study METHODS/STUDY POPULATION: Participants are 30-75 years old and include 10 healthy subjects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stremke, Elizabeth, Wiese, Gretchen, Wright, Amy, Moe, Sharon, Moorthi, Ranjani, Gallant, Kathleen Hill
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2019
Materias:	Clinical Epidemiology/Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799606/ http://dx.doi.org/10.1017/cts.2019.120

Ejemplares similares

4438 Twenty-four-hour Urinary Sodium Excretion Estimated from a Spot Urine Sample May Be Used as an Indicator of Intake in CKD Patients
por: Lobene, Andrea, et al.
Publicado: (2020)

Intestinal Phosphorus Absorption in Chronic Kidney Disease
por: Stremke, Elizabeth R., et al.
Publicado: (2018)

Effect of dietary phosphorus intake and age on intestinal phosphorus absorption efficiency and phosphorus balance in male rats
por: Vorland, Colby J., et al.
Publicado: (2018)

3574 Effect modification between kidney function and adiposity in the association with central and peripheral insulin sensitivity among Nondiabetic patients with moderate Chronic Kidney Disease and Healthy Controls
por: Akwo, Elvis, et al.
Publicado: (2019)

4063 Glycemic control in a weight management-focused group medical visits (WM/GMV) intervention: examining the moderating effects of body mass index (BMI)
por: Kobe, Elizabeth, et al.
Publicado: (2020)

MD3318 – Impedance Contribution of Secondary and Tertiary Collimators
por: Amorim, David, et al.
Publicado: (2020)

No major effects of vitamin D(3) (1,25 dihydroxyvitamin D(3)) on absorption and pharmacokinetics of folic acid and fexofenadine in healthy volunteers
por: Kullak-Ublick, Gerd A., et al.
Publicado: (2016)

3577 Adiposity and Fibroblast Growth Factor 23 in nondiabetic patients with moderate-to-severe Chronic Kidney Disease
por: Akwo, Elvis, et al.
Publicado: (2019)

Absorption and safety of serum-derived bovine immunoglobulin/protein isolate in healthy adults
por: Shaw, Audrey L, et al.
Publicado: (2016)

3526 Healthy eating, physical activity, sleep and cognitive function in elderly population: Data from National Health and Nutrition Examination Survey 2011-2014
por: Shaheen, Magda
Publicado: (2019)

4327 Structural Neural Correlates of Social Functioning in First Episode Psychosis and Malleability in Response to Targeted Cognitive Training
por: Miley, Kathleen, et al.
Publicado: (2020)

3049 Prenatal care as a protective factor for preterm birth and smoking during pregnancy in nulliparous patients: a propensity score analysis
por: Houston-Ludlam, Alexandra Noel, et al.
Publicado: (2019)

Topical administration of regorafenib eye drops: phase I dose‐escalation study in healthy volunteers
por: Zimmermann, Torsten, et al.
Publicado: (2018)

4575 Implementing a Workflow Management Tool for Clinical Trials
por: Hanson, Laura Nelle, et al.
Publicado: (2020)

4417 Association between Brain Volumes and Posttraumatic Stress Disorder in Intensive Care Unit Survivors
por: Wilson, Jo Ellen, et al.
Publicado: (2020)

3341 Sex Differences in Vitamin D and Urinary Stone Disease
por: Di Florio, Damian Nicolas, et al.
Publicado: (2019)

4036 POSITIVE EXPERIENCE OF INFORMED CONSENT UNDERSTANDING AT A METROPOLITAN MULTI-INSTITUTIONS CTSA HUB
por: Otado, Jane Anyasa, et al.
Publicado: (2020)

Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemia
por: Vissers, Maud N., et al.
Publicado: (2008)

Acute High Dietary Phosphorus Following Low‐Phosphorus Diet Acclimation Does Not Enhance Intestinal Fractional Phosphorus Absorption in Nephrectomized Male Rats
por: Burstad, Kendal M, et al.
Publicado: (2022)

The effect of mild and moderate renal impairment on the pharmacokinetics of pridopidine, a new drug for Huntington's disease
por: Rabinovich‐Guilatt, L., et al.
Publicado: (2015)

Internet-delivered therapist-guided physical activity for mild to moderate depression: a randomized controlled trial
por: Ström, Morgan, et al.
Publicado: (2013)

Safety and Comfort of an Innovative Drug Delivery Device in Healthy Subjects
por: Bertens, Christian J. F., et al.
Publicado: (2020)

445 The effects of dietary fiber based on fermentability and viscosity on phosphorus absorption and the gut microbiome in chronic kidney disease-mineral and bone disorder
por: Biruete, Annabel, et al.
Publicado: (2023)

Safety and Feasibility of Long-term Intravenous Sodium Nitrite Infusion in Healthy Volunteers
por: Pluta, Ryszard M., et al.
Publicado: (2011)

Pharmacokinetic and pharmacodynamic effects of comedication of clopidogrel and dabigatran etexilate in healthy male volunteers
por: Härtter, Sebastian, et al.
Publicado: (2012)

Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects
por: Moore, Kenneth Todd, et al.
Publicado: (2015)

Effects of a self-management program on antiemetic-induced constipation during chemotherapy among breast cancer patients: a randomized controlled clinical trial
por: Hanai, Akiko, et al.
Publicado: (2015)

Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QT(c) interval in healthy subjects
por: Darpö, Börje, et al.
Publicado: (2013)

TOPS: an internet-based system to prevent healthy subjects from over-volunteering for clinical trials
por: Boyce, M., et al.
Publicado: (2012)

An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subjects
por: Round, Patrick, et al.
Publicado: (2011)

Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects
por: Singh, Dave, et al.
Publicado: (2015)

Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjects
por: Täubel, Jörg, et al.
Publicado: (2016)

Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira(®) in healthy subjects
por: Hyland, Elizabeth, et al.
Publicado: (2016)

Safety, pharmacokinetics, and pharmacodynamics of BMS-986142, a novel reversible BTK inhibitor, in healthy participants
por: Lee, Sun Ku, et al.
Publicado: (2017)

2285: Analysis of racial disparity in the whole blood and plasma of healthy volunteers using rotational thromboelastometry
por: Janbain, Maissaa, et al.
Publicado: (2018)

The effect of potent CYP2D6 inhibition on the pharmacokinetics and safety of deutetrabenazine in healthy volunteers
por: Schneider, F., et al.
Publicado: (2021)

Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
por: Kohan, Donald E, et al.
Publicado: (2014)

Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects
por: Boettcher, Michael, et al.
Publicado: (2020)

Plasma FGF21 concentrations are regulated by glucose independently of insulin and GLP-1 in lean, healthy humans
por: Solomon, Thomas P.J., et al.
Publicado: (2022)

3542 Torsade de pointes/QT prolongation risks with antibiotics: A contemporary analysis of the FDA Adverse Event Reporting System
por: Teng, Chengwen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0i14jq92u6dc611kq7c9m08nnt